Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Amortization of Deferred Charges (2016 - 2019)

Historic Amortization of Deferred Charges for Integra Lifesciences Holdings (IART) over the last 11 years, with Q4 2019 value amounting to $1.3 million.

  • Integra Lifesciences Holdings' Amortization of Deferred Charges fell 83.52% to $1.3 million in Q4 2019 from the same period last year, while for Dec 2019 it was $5.4 million, marking a year-over-year decrease of 1403.51%. This contributed to the annual value of $5.4 million for FY2019, which is 1403.51% down from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Amortization of Deferred Charges of $1.3 million as of Q4 2019, which was down 83.52% from $1.4 million recorded in Q3 2019.
  • Over the past 5 years, Integra Lifesciences Holdings' Amortization of Deferred Charges peaked at $2.1 million during Q2 2018, and registered a low of $387000.0 during Q3 2016.
  • For the 5-year period, Integra Lifesciences Holdings' Amortization of Deferred Charges averaged around $958750.0, with its median value being $763000.0 (2016).
  • Per our database at Business Quant, Integra Lifesciences Holdings' Amortization of Deferred Charges plummeted by 3693.55% in 2017 and then surged by 44680.31% in 2018.
  • Integra Lifesciences Holdings' Amortization of Deferred Charges (Quarter) stood at $619000.0 in 2015, then surged by 46.37% to $906000.0 in 2016, then soared by 70.42% to $1.5 million in 2017, then dropped by 14.7% to $1.3 million in 2018, then decreased by 0.84% to $1.3 million in 2019.
  • Its Amortization of Deferred Charges stands at $1.3 million for Q4 2019, versus $1.4 million for Q3 2019 and $1.4 million for Q2 2019.